u/elise_grimaldi

Compared two draws across two labs and spent a week worrying before finding out the assays were different.

Nothing on this board is medical advice, and the people answering you — including me — are members with spreadsheets rather than clinicians.

Kept a log with every date, name of department and reference number. When they claimed no record of a call, I had the reference.

A certificate with a purity figure and no method line is not falsifiable. You cannot reproduce it, you cannot check it, and it tells you nothing about how the number was produced.

My ALT moved and I spent a fortnight convinced I knew why. The repeat six weeks later was back in range and I had changed nothing.

the wider-market names in the table are there because nobody has enough data on them

This. Step therapy is a paperwork requirement and it is beaten with documentation, not persuasion.

Disagree that the pace matters as much as you think. Durable is better than fast and nobody posts about durable.

Not convinced. That is a formulary exclusion rather than a prior authorisation denial, and the route to challenge it is different.

Mild pushback: a supplier with fewer entries is not worse, it is less sampled. Those are different claims and the table says so.

Regional stock made more difference to my planning than anything else — ordering from a warehouse in the UK took the customs question off the table entirely.

step therapy is a documentation problem, not an argument

Yes — quoting their own policy bulletin back at them is far more effective than arguing in general terms.

This is the whole method. Answer the criterion they named, not the decision in general.

This. Reference ranges are population intervals, not targets, and conflating them causes a lot of unnecessary alarm here.

search first, but a repeat question is not a crime

Agreed, and for anyone finding this later: that is the normal experience, not a warning sign.

Text-only posting removes the comparison mechanism that makes image boards difficult, which is why this community adopted the rule and has kept it.

waist is the measurement that keeps moving during a scale stall

rasmus_kuipers is right that the clothes tell you before the scale does.

A denial letter is required to state a reason and to reference the criterion applied. That reference is the handle: request the clinical policy document by its identifier and answer it point by point.

Correction: that supplier is in the documented twenty with a source page, not in the wider-market table. Different evidence bases entirely.

Not quite. Bacteriostatic and sterile water are different products and only one is intended for repeated entry.

Prior authorisation criteria are republished each plan year. A criterion that blocked you in one year may not exist in the next, so a denial is worth retesting after the turnover.

Agreed that goal weights picked at the start are guesses. Mine was, and I revised it twice.

employer plans and individual plans are different fights

Disagreeing with this line: the deadline runs from the letter date and treating it otherwise is expensive.

bring the numbers to someone qualified to read them

registration number, then everything else

the source page log is more useful than the score above it

Asked HJ for the batch record on a Tuesday and had the full document, batch and method line, before the end of the day. That is the bar now.